Subtle renal dysfunction and bleeding risk in atrial fibrillation: symmetric dimethylarginine predicts HAS-BLED score

Background: Risk of substantial haemorrhage represents a critically important limitation to effective anti-thrombotic treatment in patients with atrial fibrillation (AF). While it is known that this risk is increased in anticoagulated patients either in the presence of anti-aggregatory drugs or conc...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Am J Cardiovasc Dis
Prif Awduron: Procter, Nathan EK, Ball, Jocasta, Heresztyn, Tamila, Nooney, Vivek B, Liu, Saifei, Chong, Cher-Rin, Ngo, Doan TM, Isenberg, Jeffrey S, Chirkov, Yuliy Y, Stewart, Simon, Horowitz, John D
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: e-Century Publishing Corporation 2015
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4539096/
https://ncbi.nlm.nih.gov/pubmed/26309773
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg